These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 10220412)
1. Induction of a secreted protein by the myxoid liposarcoma oncogene. Kuroda M; Wang X; Sok J; Yin Y; Chung P; Giannotti JW; Jacobs KA; Fitz LJ; Murtha-Riel P; Turner KJ; Ron D Proc Natl Acad Sci U S A; 1999 Apr; 96(9):5025-30. PubMed ID: 10220412 [TBL] [Abstract][Full Text] [Related]
2. TLS-CHOP target gene DOL54 expression in liposarcomas and malignant fibrous histiocytomas. Domoto H; Hosaka T; Oikawa K; Ohbayashi T; Ishida T; Izumi M; Iwaya K; Toguchida J; Kuroda M; Mukai K Pathol Int; 2002 Aug; 52(8):497-500. PubMed ID: 12366807 [TBL] [Abstract][Full Text] [Related]
3. Oncogenic transformation and inhibition of adipocytic conversion of preadipocytes by TLS/FUS-CHOP type II chimeric protein. Kuroda M; Ishida T; Takanashi M; Satoh M; Machinami R; Watanabe T Am J Pathol; 1997 Sep; 151(3):735-44. PubMed ID: 9284822 [TBL] [Abstract][Full Text] [Related]
4. Chimeric TLS/FUS-CHOP gene expression and the heterogeneity of its junction in human myxoid and round cell liposarcoma. Kuroda M; Ishida T; Horiuchi H; Kida N; Uozaki H; Takeuchi H; Tsuji K; Imamura T; Mori S; Machinami R Am J Pathol; 1995 Nov; 147(5):1221-7. PubMed ID: 7485386 [TBL] [Abstract][Full Text] [Related]
5. The myxoid liposarcoma specific TLS-CHOP fusion protein localizes to nuclear structures distinct from PML nuclear bodies. Thelin-Järnum S; Göransson M; Burguete AS; Olofsson A; Aman P Int J Cancer; 2002 Feb; 97(4):446-50. PubMed ID: 11802205 [TBL] [Abstract][Full Text] [Related]
6. A novel effector domain from the RNA-binding protein TLS or EWS is required for oncogenic transformation by CHOP. Zinszner H; Albalat R; Ron D Genes Dev; 1994 Nov; 8(21):2513-26. PubMed ID: 7958914 [TBL] [Abstract][Full Text] [Related]
7. Detection of TLS/FUS-CHOP fusion transcripts in myxoid and round cell liposarcomas by nested reverse transcription-polymerase chain reaction using archival paraffin-embedded tissues. Hisaoka M; Tsuji S; Morimitsu Y; Hashimoto H; Shimajiri S; Komiya S; Ushijima M Diagn Mol Pathol; 1998 Apr; 7(2):96-101. PubMed ID: 9785008 [TBL] [Abstract][Full Text] [Related]
8. Characteristics of genomic breakpoints in TLS-CHOP translocations in liposarcomas suggest the involvement of Translin and topoisomerase II in the process of translocation. Kanoe H; Nakayama T; Hosaka T; Murakami H; Yamamoto H; Nakashima Y; Tsuboyama T; Nakamura T; Ron D; Sasaki MS; Toguchida J Oncogene; 1999 Jan; 18(3):721-9. PubMed ID: 9989822 [TBL] [Abstract][Full Text] [Related]
9. Human translocation liposarcoma-CCAAT/enhancer binding protein (C/EBP) homologous protein (TLS-CHOP) oncoprotein prevents adipocyte differentiation by directly interfering with C/EBPbeta function. Adelmant G; Gilbert JD; Freytag SO J Biol Chem; 1998 Jun; 273(25):15574-81. PubMed ID: 9624148 [TBL] [Abstract][Full Text] [Related]
10. Identification of genes differentially expressed in TLS-CHOP carrying myxoid liposarcomas. Thelin-Järnum S; Lassen C; Panagopoulos I; Mandahl N; Aman P Int J Cancer; 1999 Sep; 83(1):30-3. PubMed ID: 10449603 [TBL] [Abstract][Full Text] [Related]
11. Molecular variability of TLS-CHOP structure shows no significant impact on the level of adipogenesis: a comparative ultrastructural and RT-PCR analysis of 14 cases of myxoid/round cell liposarcomas. Huang HY; Antonescu CR Ultrastruct Pathol; 2003; 27(4):217-26. PubMed ID: 12907366 [TBL] [Abstract][Full Text] [Related]
12. Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma. Crozat A; Aman P; Mandahl N; Ron D Nature; 1993 Jun; 363(6430):640-4. PubMed ID: 8510758 [TBL] [Abstract][Full Text] [Related]
13. Specificity of TLS-CHOP rearrangement for classic myxoid/round cell liposarcoma: absence in predominantly myxoid well-differentiated liposarcomas. Antonescu CR; Elahi A; Humphrey M; Lui MY; Healey JH; Brennan MF; Woodruff JM; Jhanwar SC; Ladanyi M J Mol Diagn; 2000 Aug; 2(3):132-8. PubMed ID: 11229517 [TBL] [Abstract][Full Text] [Related]
14. RNA splicing mediated by YB-1 is inhibited by TLS/CHOP in human myxoid liposarcoma cells. Rapp TB; Yang L; Conrad EU; Mandahl N; Chansky HA J Orthop Res; 2002 Jul; 20(4):723-9. PubMed ID: 12168660 [TBL] [Abstract][Full Text] [Related]
15. TLS-CHOP and the role of RNA-binding proteins in oncogenic transformation. Ron D Curr Top Microbiol Immunol; 1997; 220():131-42. PubMed ID: 9103679 [No Abstract] [Full Text] [Related]
16. Prognostic impact of P53 status, TLS-CHOP fusion transcript structure, and histological grade in myxoid liposarcoma: a molecular and clinicopathologic study of 82 cases. Antonescu CR; Tschernyavsky SJ; Decuseara R; Leung DH; Woodruff JM; Brennan MF; Bridge JA; Neff JR; Goldblum JR; Ladanyi M Clin Cancer Res; 2001 Dec; 7(12):3977-87. PubMed ID: 11751490 [TBL] [Abstract][Full Text] [Related]
17. A novel oncogenic pathway by TLS-CHOP involving repression of MDA-7/IL-24 expression. Oikawa K; Tanaka M; Itoh S; Takanashi M; Ozaki T; Muragaki Y; Kuroda M Br J Cancer; 2012 Jun; 106(12):1976-9. PubMed ID: 22588557 [TBL] [Abstract][Full Text] [Related]
18. Translin binds to the sequences adjacent to the breakpoints of the TLS and CHOP genes in liposarcomas with translocation t(12;6). Hosaka T; Kanoe H; Nakayama T; Murakami H; Yamamoto H; Nakamata T; Tsuboyama T; Oka M; Kasai M; Sasaki MS; Nakamura T; Toguchida J Oncogene; 2000 Nov; 19(50):5821-5. PubMed ID: 11126370 [TBL] [Abstract][Full Text] [Related]
19. Liposarcoma initiated by FUS/TLS-CHOP: the FUS/TLS domain plays a critical role in the pathogenesis of liposarcoma. Pérez-Losada J; Sánchez-Martín M; Rodríguez-García MA; Pérez-Mancera PA; Pintado B; Flores T; Battaner E; Sánchez-Garćia I Oncogene; 2000 Dec; 19(52):6015-22. PubMed ID: 11146553 [TBL] [Abstract][Full Text] [Related]